<DOC>
	<DOC>NCT00799331</DOC>
	<brief_summary>The aim of this exploratory study is to assess the pharmacokinetics of increasing oral doses of AZD5985 in healthy male volunteers</brief_summary>
	<brief_title>Exploratory Study to Assess the Pharmacokinetics of AZD5985</brief_title>
	<detailed_description />
	<criteria>Provision of signed, written and dated informed consent prior to any study specific procedures. Healthy male subjects aged 18 to 45 years (inclusive). Have a body mass index (BMI) between 19 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg. Be nonsmoker or exsmoker who has stopped smoking (or using other nicotine products) for &gt;6 months prior to study start. History or presence of any clinically significant disease or disorder in the opinion of the investigator. Any clinically relevant abnormal findings in physical examination, clinical chemistry, haematology, urinalysis, vital signs or ECG at baseline in the opinion of the investigator. Participation in another investigational drug study within 3 months before Visit 2 or participation in a method development study (no drug) 1 month prior to Visit 2</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Healthy volunteers</keyword>
</DOC>